75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) 2 link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Nature of Business link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Liquidity link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Basis of Presentation and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Equipment link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Supplemental Condensed Consolidated Balance Sheet Information link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - ATM Program/Open Market Sales Agreement link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Acquisition of CorHepta link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - ABLi License Agreement link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Correction of Prior Period Immaterial Error link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Basis of Presentation and Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Equipment and Improvements (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Supplemental Condensed Consolidated Balance Sheet Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Acquisition of CorHepta (Tables) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Correction of Prior Period Immaterial Error (Tables) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Nature of Business (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Liquidity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Basis of Presentation and Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Basis of Presentation and Significant Accounting Policies - classified as fixed assets useful life (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Fair Value of Financial Instruments - Summary of cash equivalents and marketable securities measured at their fair value (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Fair Value of Financial Instruments - Summary of contingent consideration related to acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Marketable securities Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Equipment and Improvements - Schedule of Equipment and Improvements (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Equipment Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Supplemental Condensed Consolidated Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - ATM Program/Open Market Sales Agreement (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Notes Payable - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Stockholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Acquisition of CorHepta (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Acquisition of CorHepta - Schedule of Fair Value of Consideration Transferred (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Acquisition of CorHepta - Schedule of Allocation of Consideration Transferred (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - ABLi License Agreement (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Stock-based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Net Loss Per Share - Summary of Calculation of Basic and Diluted Net Loss Per Share applicable to Common Stockholders (Details) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Net Loss Per Share (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Net Loss Per Share - Summary of Shares Excluded from Calculation of Diluted Net Loss per Share Applicable to Common Stockholders (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Commitments and Contingencies (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Commitments and Contingencies - Estimated Contractual Commitments Under Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Commitments and Contingencies - Estimated Contractual Commitments Agreements (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 996065 - Disclosure - Correction of Prior Period Immaterial Error - Schedule of Error Corrections and Prior Period Adjustments (Details) link:presentationLink link:calculationLink link:definitionLink 996075 - Disclosure - Segment Information (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996085 - Disclosure - Segment Information - Schedule of financial information regularly reviewed and used by the CODM (Details) link:presentationLink link:calculationLink link:definitionLink 996095 - Disclosure - Segment Information - Schedule of financial information regularly reviewed and used by the CODM (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 996105 - Disclosure - Subsequent Event (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink Share subscription price Common Stock, Value, Subscriptions Shares Unvested Shares Unvested On Acquisition Shares Unvested On Acquisition Other Research and Development Expense Other research and development Segments [Domain] Lessor, Operating Lease, Description Lessor, Operating Lease, Description Concentration Risk Type Concentration Risk Type [Axis] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Preferred stock, shares issued Preferred Stock, Shares Issued Preferred Stock, Shares Issued, Total Statement of Financial Position Location, Balance [Domain] Accounts payable Increase (Decrease) in Accounts Payable Increase (Decrease) in Accounts Payable, Total Revision of Prior Period [Axis] Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Non cash investing and financing activities Plan Name [Axis] Research and Development Expense [Abstract] Research and development (excluding stock-based compensation) expense: Equity [Abstract] Entity Current Reporting Status Entity Current Reporting Status Issue date Debt Instrument, Issuance Date Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Warrants to Purchase Shares of Stock Warrants To Purchase Shares Of Stock [Member] Warrants to purchase shares of stock. Common stock, shares authorized Common Stock, Shares Authorized Document Fiscal Period Focus Document Fiscal Period Focus Annual interest rate Debt Instrument, Interest Rate, Stated Percentage Entity Shell Company Entity Shell Company Contractual Obligation Contractual Obligation, Total Total commitment Accrued other Other Accrued Liabilities, Current Schedule of Gain (Loss) on Securities [Table] Segment Information Segment Reporting, Policy [Policy Text Block] Notes payable outstanding balance Notes payable Notes Payable, Current Notes Payable, Current, Total Summary of estimated contractual commitments under agreements Estimated Contractual Commitments Under Agreements [Table Text Block] Estimated Contractual Commitments Under Agreements [Table Text Block] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary of significant accounting policies. Common stock, shares issued Common Stock, Shares, Issued Common Stock, Shares, Issued, Total Statement [Table] Statement [Table] Service And Performance Based Vesting Shares Service And Performance Based Vesting Shares Service and performance based vesting shares Increase (Decrease) in Prepaid Expense Prepaid expense Placement Agent Warrants [Member] Placement Agent Warrants [Member] Placement Agent Warrants [Member] Percentage of Common Stock Outstanding, During Period Increase (Decrease) Percentage of Common Stock Outstanding, During Period Increase (Decrease) Percentage of Common Stock Outstanding Statement [Line Items] Statement [Line Items] Business Combination [Domain] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Warrant [Member] Warrant [Member] Entity Filer Category Entity Filer Category Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Indefinite-Lived Acquired IPR&D Liabilities and Equity Total liabilities and stockholders' equity Business Combination, Recognized Liability Assumed, Liability, Current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Total Current liabilities Debt Instrument [Line Items] Debt Instrument [Line Items] Payments to Acquire Marketable Securities Purchases of investments - marketable securities Purchases of investments - marketable securities Long-Lived Tangible Asset [Axis] Accrued consulting Accrued Consulting Current Accrued consulting current. Prepaid Expenses and Other Current Assets [Member] Net proceeds Proceeds from Issuance of Debt Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents and marketable securities measured at their fair value on a recurring basis Cash equivalents Settlement of notes including principal balance plus accrued and unpaid interest Extinguishment of Debt, Amount Subsequent Event [Line Items] Schedule of Error Corrections and Prior Period Adjustments Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] Operating lease liabilities Operating lease liabilities Increase Decrease In Operating Lease Liabilities Increase Decrease In Operating Lease Liabilities. Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited Shares forfeited Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock, Ending Balance Property, Plant and Equipment [Line Items] Notes Payable [Abstract] Maturity description Debt Instrument, Maturity Date, Description Vesting [Domain] Number of stock options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Summary of Calculation of Basic and Diluted Net Loss Per Share applicable to Common Stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Notes Payable A O N Notes Payable A O N [Member] Notes payable aon. Net loss per share - basic Net loss per share applicable to common stockholders - basic Earnings Per Share, Basic Earnings Per Share, Basic, Total Other current liabilities Other Liabilities, Fair Value Disclosure Liabilities, Current Total current liabilities Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Subsegments [Axis] Contingently Issuable Common Stock Subject To Vesting Criteria, Value Contingently issuable common stock subject to vesting criteria, value Contingently Issuable Common Stock Subject To Vesting Criteria, Value Payments Related To Acquisition Payments Related To Acquisition Payments Deferred offering costs Payments of Debt Issuance Costs New board of Director [Member] New board of Director [Member] New board of Director Stockholders’ equity: Equity, Attributable to Parent [Abstract] 2019 Note Two Thousand And Nineteen Note [Member] Two thousand and nineteen note. Entity Small Business Entity Small Business Plan modification Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms Accumulated deficit Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Ending Balance Accumulated deficit Other Commitments [Line Items] Nature of Business Nature of Operations [Text Block] Number of Shares, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Sale of common stock Sale of Stock, Price Per Share Sale of common stock per Share Percentage of loan proceeds expended on qualified payroll costs Percentage Of Loan Proceeds Expended On Qualified Payroll Costs Percentage of loan proceeds expended on qualified payroll costs. Common stock Aggregate offering price Common stock Aggregate offering price Common stock Aggregate offering price Settlement Agreement Settled Litigation [Member] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] CorHepta Pharmaceuticals [Member] CorHepta Pharmaceuticals [Member] CorHepta Pharmaceuticals [Member] Amendment Flag Amendment Flag Loss Contingencies [Line Items] Employee [Member] Employee [Member] Employee Common warrants issued for purchase of common shares Class of Warrant or Right, Number of Securities Called by Warrants or Rights Class of warrant or right number of securities called by warrants or rights Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Contigent Payment of Performance Milestones Contigent Payment of Performance Milestones Contigent payment of performance milestones Common Stock Common Stock [Member] Shares Representing Post-Merger Compensation Expense Shares Representing Post-Merger Compensation Expense Shares representing post-merger compensation expense Votes per each common stock share Common Stock Per Share Entitled To Vote Common stock per share entitled to vote. Estimated Remaining Contract Costs Estimated Remaining Contract Costs Estimated total remaining contract costs Performance milestones commitment Performance Milestones Commitment Performance Milestones Payment Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Address, Address Line One Entity Address, Address Line One Marketable Securities [Table] Fair Value Hierarchy and NAV [Axis] Earnings Per Share [Abstract] Supplemental disclosures of cash flow information Supplemental Cash Flow Information [Abstract] Statement of Financial Position Location, Balance [Axis] Operating lease right of use assets Operating Lease, Right-of-Use Asset Right-of-use asset Fourteen U S Treasury Debt Securities [Member] Fourteen U S Treasury Debt Securities [Member] Document Type Document Type 2020 plan. Two Thousand And Twenty Plan [Member] 2020 Plan Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Payments Of Issuance of Common Stock Consideration Payments Of Issuance of Common Stock Consideration Issuance of common stock Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Entity Central Index Key Entity Central Index Key Marketable Securities, Obligations Maturity Period Marketable Securities, Obligations Maturity Period Marketable securities, obligations maturity period Investments, Debt and Equity Securities [Abstract] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Net increase (decrease) in cash and cash equivalents Subsequent Event Type [Domain] Initial fair value of Warrants Warrant expense/ Issuance of warrants Fair Value Adjustment of Warrants Antidilutive shares excluded from calculation of diluted net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Armistice Capital Master Fund Ltd [Member] Armistice [Member] Armistice [Member] Common stock, par value Common Stock, Par or Stated Value Per Share Number of Clinical Sites Number of Clinical Sites Number of Clinical Sites Security deposit Security Deposit Clinical Research Study Clinical Research Study Proceeds from Issuance of Warrants Warrant issued Share-Based Payment Arrangement, Tranche One [Member] One Debt Asset Acquisition, Contingent Consideration, Liability Asset Acquisition, Contingent Consideration, Liability, Total Contingent consideration Additions Marketable securities, , available-for-sale Debt Securities, Available-for-Sale, Amortized Cost, Total Debt Securities, Available-for-Sale, Amortized Cost Non Cash Financing Contingent Consideration Non Cash Financing Contingent Consideration Contingent consideration Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Issuance of common stock, stock options exercised, Shares Debt Disclosure [Abstract] Marketable Securities Marketable securities Marketable securities, Fair Value Marketable securities Total accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities, Current Stock Issued During Period, Value, Restricted Stock Award, Gross Restricted stock awards issued Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Debt Instrument [Table] Schedule of Long-Term Debt Instruments [Table] Document Quarterly Report Document Quarterly Report Other Accrued Liabilities Accrued compensation Entity Address, State or Province Entity Address, State or Province Asset Acquisition [Domain] Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance October Two Thousand Twenty Four Offering [Member] October Two Thousand Twenty Four Offering [Member] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Common stock shares reserved for issuance Common Stock, Capital Shares Reserved for Future Issuance Business Combination, Transaction Cost, Excluding Separately Recognized Transaction Transaction costs incurred by the Company Marketable Securities, Current Marketable securities Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Business Combination Contingent Consideration Paid Noncash Business Combination Contingent Consideration Paid Noncash Settlement of contingent consideration liability Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock, stock options exercised, Value Collaborative Arrangement Disclosure [Text Block] ABLi License Agreement Performance Shares [Member] Performance-based options [Member] Proceeds from Sale and Maturity of Marketable Securities Proceeds from maturities of marketable securities Subsequent Event [Member] Subsequent Event [Member] Marketable Securities, Policy [Policy Text Block] Marketable Securities Paycheck Protection Program Paycheck Protection Program [Member] Paycheck protection program. Property, Plant and Equipment [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Other Assets, Noncurrent Other assets Antidilutive Securities Antidilutive Securities [Axis] Basis of Presentation and Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Stock option, aggregate grant date fair value Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value Share-based compensation arrangement by share-based payment award options grants in period grant date fair value. Stock option, aggregate grant date fair value Related Party Transaction [Axis] AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) Master Services Agreement [Member] Master Services Agreement [Member] Master Services Agreement Member Other Commitments [Table] Summary of contingent consideration related to acquisition Asset Acquisition, Contingent Consideration [Table Text Block] Business Combination, Consideration Transferred Consideration transferred Fair value of consideration Lessor, Lease, Description [Table] Preferred Stock, Value, Issued Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Ending Balance Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025 Selling, general and administrative Selling, General and Administrative Expense Selling, General and Administrative Expense, Total Maturity date Debt Instrument, Maturity Date Minimum Minimum [Member] Financial Instrument [Axis] Current assets: Assets, Current [Abstract] Other Comprehensive Income (Loss), Tax Other Comprehensive Income (Loss), Tax, Total Other comprehensive income loss Phase Two [Member] Phase Two [Member] Phase 2 Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Segment Reporting [Abstract] Wainwright Agreement [Member] Wainwright Agreement [Member] Wainwright Agreement [Member] Fair Value, Assets Measured on Recurring Basis [Table Text Block] Summery of Fair Value Assets Measured On Recurring Basis Current liabilities: Liabilities, Current [Abstract] Loan forgiveness terms Loan Forgiveness Terms Loan forgiveness terms. Accrued research and development Accrued Research And Development Current Accrued research and development current. Prepaid research and development, noncurrent Prepaid Expense, Noncurrent Prepaid Expense, Noncurrent, Total Commitments and Contingencies Commitments and contingencies Leases Lessee, Leases [Policy Text Block] Present value of operating lease liabilities Operating Lease, Liability Present value of operating lease liabilities Operating lease Obligation Present value of operating lease liabilities Error Corrections and Prior Period Adjustments Restatement [Line Items] Concentration Risk Benchmark Concentration Risk Benchmark [Axis] Vendor. Vendor [Member] Vendor 2020 Note Two Thousand And Twenty Note [Member] Two thousand and twenty note. CEO Restated Note C E O Restated Note C E O Restated Note [Member] Ceo restated note. Impairment Effects on Earnings Per Share [Table] Interest Income (Expense), Operating Interest Income (Expense), Net, Total Other Income ATM Facility [Member] ATM Facility [Member] ATM Facility [Member] Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Cash Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total Weighted-average number of shares_ basic Cash, cash equivalents and marketable securities Cash Equivalents And Marketable Securities Cash Equivalents and Marketable Securities Segments [Axis] Long-Lived Tangible Asset [Domain] Performance-based options, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total Accrued interest Interest Payable Proceeds from Issuance of Private Placement Gross proceeds from agent (Private Placement) Net proceeds from agent (Private Placement) Subsequent Events Subsequent Events [Text Block] Cash and cash equivalents Cash Cash, Beginning Balance Cash, Ending Balance Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Sales Agreement [Member] Sales Agreement [Member] Sales Agreement [Member] Written off Written off As Research And Development Expense Written off As Research And Development Expense Beginning balance Ending balance Equity, Attributable to Parent Total stockholders' equity Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Statement of Stockholders' Equity [Abstract] Series C [Member] Series C Preferred Stock [Member] Share-Based Payment Arrangement, Tranche Two [Member] Two Debt Series A [Member] Series A Preferred Stock [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] Leaseholds and Leasehold Improvements [Member] Leasehold property improvements, right of use asset June 2021 Offering Over-Allotment Option [Member] Offering Entity Address, Address Line Two Entity Address, Address Line Two Write-off of in-process research and development Write Off of In Process Research and Development Write Off of In Process Research and Development Fair Value Disclosures [Text Block] Fair Value of Financial Instruments Warrants and Rights Note Disclosure [Abstract] Securities purchase agreements [Member] Securities Purchase Agreements [Member] Securities Purchase Agreements [Member] Debt Instrument, Name Debt Instrument, Name [Domain] CorHepta [Member] CorHepta [Member] Asset Acquisitions Asset Acquisitions Policy Asset Acquisitions In Process Research and Development [Member] In Process Research and Development [Member] Plan Name [Domain] Increase (Decrease) in Other Operating Assets Increase (Decrease) in Other Operating Assets, Total Other assets Entity [Domain] Issuance of common stock, pre-funded warrants and warrants, net of issuance costs Stock Issued During Period, Value, Other Class of Warrant or Right, Outstanding Pre-funded warrants outstanding Warrants outstanding On event of default Debt Default, Short-Term Debt, Description of Violation or Event of Default Related Party Related and Nonrelated Parties [Axis] Equipment and Improvements Property, Plant and Equipment, Policy [Policy Text Block] Entity Address, City or Town Entity Address, City or Town Number of Reportable Segments Number of Reportable Segments Security Exchange Name Security Exchange Name Prepaid research and development Increase Decrease In Prepaid Research And Development Increase (decrease) in prepaid research and development. Business Combination, Date of Acquisition Agreement Date of acquisition agreement Debt instrument, carrying amount Long-Term Debt, Gross Property, Plant and Equipment, Gross Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross Debt Securities, Available-for-Sale, Unrealized Gain (Loss), Total Debt Securities, Available-for-Sale, Unrealized Gain (Loss) Marketable securities, Unrealized Gain Marketable securities, Unrealized Loss Marketable securities, Net Unrealized Loss Deferred Offering Costs Deferred offering costs Concentration Risk Type Concentration Risk Type [Domain] Maturities of investments - marketable securities Maturities of Investments - Marketable Securitie Maturities of Investments - Marketable Securitie Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Operating Segment [Member] Operating Segment [Member] Operating Segment Stockholders' Equity Note [Abstract] Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statistical Measurement Statistical Measurement [Domain] Shares Representing Contingent Consideration Shares Representing Contingent Consideration Shares representing contingent consideration Warrants exercise price Class of Warrant or Right, Exercise Price of Warrants or Rights Total current assets Assets, Current Total stock-based compensation expense Share-Based Payment Arrangement, Expense Stock-based compensation expense Document Period End Date Document Period End Date Forward Contract Indexed to Equity, Settlement, Share, Fair Value Fair value of stock Title and Position [Axis] Title of Individual Fair Value Hierarchy and NAV [Domain] Contingently Issuable Common Shares Contingently issuable common shares Contingently Issuable Common Shares Jefferies Agreement [Member] Jefferies Agreement [Member] Jefferies Agreement [Member] Series A-1 Warrants [Member] Series A-1 Warrants [Member] Statement of Financial Position [Abstract] Contingent Consideration Liabilities Contingent Consideration Liabilities Policy Contingent Consideration Liabilities Policy Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Vesting [Axis] Class of Stock [Axis] Lab equipment Lab Equipment[Member] Lab equipment [Member] Shares subscribed for purchase Common Stock, Shares Subscribed but Unissued Total liabilities Liabilities Lessee, Operating Lease, Discount Rate Lessee, Operating Lease, Discount Rate Costs and expenses: Operating Costs and Expenses [Abstract] Financial Instruments [Domain] Property, Plant and Equipment, Estimated Useful Life Property, Plant and Equipment, Estimated Useful Life Estimated Useful Lives Restricted Stock [Member] Restricted Stock [Member] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Parkinson Disease Expense Parkinson Disease Expense Parkinson's disease Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted, Total Weighted-average number of shares_ diluted Entity File Number Entity File Number Cover [Abstract] Agent Commission Percentage of Aggreagate Gross Proceeds Agent Commission Percentage of Aggreagate Gross Proceeds Agent commission percentage of aggreagate gross proceeds ATM Agreement [Member] ATM Agreement Member ATM Agreement [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Supplemental Balance Sheet Disclosures [Text Block] Supplemental Condensed Consolidated Balance Sheet Information Performance-based options, weighted average strike price Performance-Based Options, Weighted Average Strike Price Performance-Based Options, Weighted Average Strike Price Sales Revenue Revenue Benchmark [Member] US Treasury Securities [Member] U.S. treasury debt securities U.S. Treasury obligations Other Comprehensive Income (Loss) [Member] Other Comprehensive Income Number of Operating Segments Number of Operating Segments Sale of Stock Sale of Stock [Domain] Segment Reporting Disclosure [Text Block] Segment Information Clinical Trial Supply Organization Clinical Trial Supply Organization [Member] Clinical Trial Supply Organization [Member] Series B [Member] Series B Preferred Stock [Member] Start Up Agreement [Member] Start Up Agreement [Member] Stock Issued During Period, Shares, Acquisitions Acquisition of Stock issued Schedule Of Equipment and Improvements Table [Text Block] Schedule Of Equipment and Improvements Table [Text Block] Schedule Of Equipment and Improvements Subsequent Event [Table] Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares Stock Issued During Period, Shares, Other Short-term Debt, Type Short-Term Debt, Type [Domain] Schedule Of Summary Of Significant Accounting Policy [Table] Schedule Of Summary Of Significant Accounting Policy [Table] Schedule of summary of significant accounting policy. Commitments and Contingencies Commitments Disclosure [Text Block] Operating Lease, Expense Lease Expense Marketable Securities [Abstract] Marketable securities, available-for-sale: Property, Plant and Equipment, Useful Life Estimated Useful Economic Life Short-term Debt, Type Short-Term Debt, Type [Axis] New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Summary of Future Minimum Lease Payments Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Fair Value of Fully Vested Shares Fair Value of Fully Vested Shares Fair value of fully vested shares Stock Issued During Period, Shares, Conversion of Convertible Securities Stock Issued During Period Shares Conversion Of Convertible Securities Depreciation, Total Depreciation Depreciation Less: Accumulated Depreciation Performance based vesting shares Performance Based Vesting Shares Performance Based Vesting Shares Disclosure Of Going Concerns Disclosure Of Going Concerns [Table] Common stock, shares outstanding Beginning balance, Shares Ending balance, Shares Common Stock, Shares, Outstanding IT equipment Technology Equipment [Member] Summary of Future Principal Payments on Notes Payable Contractual Obligation, Fiscal Year Maturity [Table Text Block] Document Transition Report Document Transition Report Operating Expenses Operating Expenses, Total Operating Expenses Research and Development Expense Research and Development Expense, Total Research and development Clinical research services expenses Cost of Revenue Cost of Revenue, Total Annual revenue Warrant Inducement Agreement [Member] Warrant Inducement Agreement [Member] Warrant Inducement Agreement [Member] Litigation Status [Axis] Statement of Cash Flows [Abstract] Jefferies LLC [Member] Jefferies LLC [Member] Jefferies LLC [Member] Stock Issued During Period, Value, New Issues Issuance of common stock Change In Fair Value Contingent Consideration Change In Fair Value Contingent Consideration Change in fair value contingent consideration Change in fair value Change in fair value H.C. Wainwright & Co., LLC [Member] H.C. Wainwright & Co., LLC [Member] H.C. Wainwright & Co., LLC [Member] Equity [Text Block] Stockholders' Equity Earnings Per Share [Text Block] Net Loss Per Share Shares, Issued Shares issued Network Equipment Computer Equipment [Member] Sale of Stock, Consideration Received Per Transaction Sale of Stock, Consideration Received Per Transaction Net loss Accounting Changes and Error Corrections [Abstract] Stock Issued During Period, Shares, Stock Splits Substantial Doubt about Going Concern [Text Block] Liquidity Assets Assets [Abstract] Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Prepaid Expense and Other Assets, Total Prepaid expenses and other current assets Settlement of principal amount Repayments of Debt Upfront Payment Received Upfront payment received Upfront payment Document Fiscal Year Focus Document Fiscal Year Focus Concentration Risk Benchmark Concentration Risk Benchmark [Domain] Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Accounts payable Accounts Payable, Current Accounts Payable, Current, Total Research and Development Research and Development Expense [Member] Income tax Payments Income tax Payments Income tax payments, net refund recived percentage Issuance costs Issuance Costs Issuance Costs Revision of Prior Period [Domain] Contract Manufacturing Organizations [Member] Contract Manufacturing Organizations [Member] CMO Agreements Fair Value Measurement Fair Value Measurement, Policy [Policy Text Block] Proceeds from Stock Options Exercised Issuance of common stock from exercise of stock options Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Collaboration Agreement Collaboration Agreement [Member] Collaboration Agreement [Member] Seven U S Treasury Debt Securities [Member] Seven U S Treasury Debt Securities [Member] Seven U S Treasury Debt Securities DisclosureOfGoingConcernLineItems DisclosureOfGoingConcernLineItems One U S Treasury Debt Securities [Member] One U S Treasury Debt Securities [Member] One U S Treasury Debt Securities Debt Instrument Debt Instrument [Axis] Share-Based Payment Arrangement [Abstract] Contingently issuable common stock subject to vesting criteria, shares Contingently Issuable Common Stock Subject To Vesting Criteria, Shares Contingently Issuable Common Stock Subject To Vesting Criteria, Shares Upfront Payment Upfront Payment Upfront Payment Sale of Stock Sale of Stock [Axis] Long-Term Debt and Lease Obligation, Current, Total Long-Term Debt and Lease Obligation, Current Lease obligation, current Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash provided by (used in) investing activities Private Placement [Member] Private Placement [Member] Property, Plant and Equipment, Additions Property Plant And Equipment improvements Title of 12(b) Security Title of 12(b) Security Schedule of Segment Reporting Information, by Segment [Table] Subsegments [Domain] Money Market Funds [Member] Money Market Funds [Member] Related Party Related and Nonrelated Parties [Domain] Income Taxes Income Tax Disclosure [Text Block] Equity Distribution Agreement [Member] Equity Distribution Agreement Member Equity Distribution Agreement Member Fixed commission percentage Fixed commission percentage Fixed Commission Percentage CorHepta Transaction Costs CorHepta Transaction Costs CorHepta transaction costs Milestone Liability Other Liabilities, Noncurrent Contingent Consideration [Member] Contingent Consideration [Member] Contingent Consideration [Member] Noncash Accretion On Marketable Securities Noncash Accretion On Marketable Securities Non-cash accretion on marketable securities Legal Entity [Axis] Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Business Combination, Price Per Share Share Price at Closing Property plant estimated useful life Property, Plant and Equipment [Table Text Block] Principal Balance Principal Balance [Member] Principal balance member. ATM program Text Block ATM program Text Block ATM Program/Open Market Sales Agreement Final payment due date Debt Instrument Final Payment Date Debt instrument, final payment date. Income Tax Disclosure [Abstract] Less: Accumulated depreciation Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization Acquisition of CorHepta Business Combination [Text Block] Additional Paid-In Capital Additional Paid-in Capital [Member] Measurement Frequency [Domain] Contract Research Organization [Member] Contract Research Organization [Member] CRO Agreement Income Statement Location Statement of Income Location, Balance [Axis] Trading Symbol Trading Symbol Property, Plant and Equipment Disclosure [Text Block] Equipment Director [Member] Board of Director Member Subsequent Event Type [Axis] As Adjusted Revision of Prior Period, Adjustment [Member] Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Fair Value, Recurring [Member] Fair Value, Recurring [Member] Entity Ex Transition Period Entity Ex Transition Period Lexington [Member] Lexington [Member] Lexington Pre Funded Warrant [Member] Pre Funded Warrant [Member] Pre Funded Warrant [Member] Equity Components Equity Components [Axis] DisclosureOfGoingConcernAbstract DisclosureOfGoingConcernAbstract Warrants Warrants [Text Block] Warrants. Equity Component Equity Component [Domain] Pre Funded Warrants and Shares Held In Abeyance [Member] Pre Funded Warrants and Shares Held In Abeyance [Member] Pre Funded Warrants and Shares Held In Abeyance [Member] Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] Schedule of allocation of consideration transferred Other Comprehensive Income Location [Domain] Business Combination [Axis] Marketable Securities, Realized Gain (Losses) Marketable Securities, Realized Gain (Losses) Marketable Securities, Realized Gain (Losses) Other Comprehensive Income Location [Axis] Share based Compensation Arrangement By Share based Payment Award Unrecognized Compensation Cost Share based Compensation Arrangement By Share based Payment Award Unrecognized Compensation Cost Unrecognized Compensation Cost IPO [Member] Notes payable, net of current portion Notes Payable, Noncurrent Notes Payable, Noncurrent, Total US Treasury and Government [Member] U.S. Treasury obligations [Member] Maximum Maximum [Member] Statistical Measurement Statistical Measurement [Axis] Prepaid research and development Prepaid Expense, Current Prepaid Expense, Current, Total Accrued expenses and other current liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Common Stock, Value, Issued Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Common stock, $0.001 par value; 500,000,000 shares authorized; 132,032,636 and 131,691,237 shares issued and outstanding (including 0 and 4,149,252 contingently issuable shares - see Note 10) at June 30, 2026 and December 31, 2025, respectively Insurance Premium Financing and Security Agreement Insurance Premium Financing And Security Agreement [Member] Insurance premium financing and security agreement. Litigation Status [Domain] Equipment [Member] Lab equipment Options to Purchase Shares of Stock Options To Purchase Shares Of Stock [Member] Options to purchase shares of stock. Accrued expense Accrued Liabilities Accrued Liabilities, Total Marketable Securities [Line Items] Marketable securities, available-for-sale: Entity Public Float Public float Preferred stock, shares authorized Preferred Stock, Shares Authorized Total costs and expenses Costs and Expenses Summary of Notes Payable Schedule of Debt [Table Text Block] Fair Value Of Restricted Stock Granted Fair Value Of Restricted Stock Granted Fair Value Of Restricted Stock Granted Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Employee Stock [Member] Employee stock plan Business Combination [Table] Restricted Common Stock [Member] Restricted Common Stock [Member] Restricted Common Stock Entity Registrant Name Entity Registrant Name Notes Payable Debt Disclosure [Text Block] Customer Concentration Risk Customer Concentration Risk [Member] Payments to Acquire in Process Research and Development Acquired in-process research and development Stock option, strike price Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Series D [Member] Series D Preferred Stock [Member] Subsequent Events [Abstract] Provision for income taxes Income Tax Expense (Benefit) Income Tax Expense (Benefit), Total Debt Securities, Available-for-Sale, Unrealized Loss Marketable securities, Unrealized Loss Measurement Frequency [Axis] Share based Compensation Arrangement By Share based Payment Award Options Repricing Share based Compensation Arrangement By Share based Payment Award Options Repricing Option repriced Proceeds from issuance of common stock, pre-funded warrants and warrants, net of issuance costs Proceeds from Issuance of Common Stock Costs and expenses: Costs and Expenses [Abstract] Series B-1 Warrants [Member] Series B-1 Warrants [Member] Non-cash financing costs included in accounts payable and accrued expenses Non-Cash Financing Costs Included in Accounts Payable Non-Cash Financing Costs Included in Accounts Payable Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Concentrations of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income (loss) CEO Note C E O Note [Member] CEO note. Purchases of equipment and improvements Purchases of equipment and improvements Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment, Total Total assets Assets Property, Plant and Equipment [Table] Income Statement [Abstract] Other Selling, General and Administrative Expense Selling, general and administrative (excluding stock-based compensation) Cash, Cash Equivalent, and Marketable Security [Text Block] Marketable Securities Legal Expenses Legal Fees Selling, General and Administrative Selling, General and Administrative Expenses [Member] Sale of Stock, Number of Shares Issued in Transaction Number of common stock sold Number of shares sold Issuance of common stock for services, Shares Stock Issued During Period, Shares, New Issues Issuance of common stock, Shares Business Combination [Abstract] Net loss per share - diluted Net loss per share applicable to common stockholders - diluted Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of financial information regularly reviewed and used by the CODM Error Correction [Table] Title of Individual Title and Position [Domain] Asset Acquisition [Axis] City Area Code City Area Code Sphaera Agreement Sphaera Agreement [Member] Sphaera Agreement. Comprehensive loss Other Comprehensive Income (Loss), Net of Tax Comprehensive loss Comprehensive loss Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table] Debt instrument face amount Debt Instrument, Face Amount Business Combination [Line Items] Service based vesting shares Service Based Vesting Shares Service Based Vesting Shares Phase1 Phase One [Member] Phase One [Member] Segment Reporting Information [Line Items] Restricted share issued Stock Issued During Period, Shares, Restricted Stock Award, Gross Lease Expiration Date Lease Expiration Date Award Date [Axis] Property, Plant and Equipment, Net Total Equipment and improvements, net Additions Asset Acquisition, Contingent Consideration, Liability Additions Asset Acquisition, Contingent Consideration, Liability Additions Loss from operations Operating Income (Loss) Award Date [Domain] November Two Thousand Twenty Five Offering [Member] November Two Thousand Twenty Five Offering [Member] Accumulated Deficit Retained Earnings [Member] RA Capital Management [Member] RA Capital Management [Member] RA Capital Management [Member] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Share-based Payment Arrangement, Noncash Expense, Total Performance milestones Performance Commitment, Milestones Performance Commitment, Milestones In process research and development In Process Research And Development In Process Research And Development Percentage of number of shares to value of loan Percentage Of Number Of Shares To Value Of Debt Percentage of number of shares to value of debt. Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Class Of Stock [Line Items] Class of Stock [Line Items] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by financing activities Notes payable Notes Payable Notes Payable, Total Shares vested Shares Vested on Acquisition Shares Vested on Acquisition Marketable Securities [Table Text Block] Summary of Marketable securities Summary of Shares Excluded from Calculation of Diluted Net Loss per Share Applicable to Common Stockholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Interactive Data Current Entity Interactive Data Current Basis of Presentation of Interim Financial Statements Basis Of Presentation And Principles Of Consolidation Policy [Text Block] Basis of presentation and principles of consolidation. ShortTerm Lease Payments Short-Term Lease Payments Income Statement Location Statement of Income Location, Balance [Domain] Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Furniture and office equipment Furniture and Fixtures [Member] Pulmonary Arterial Hypertension Expense Pulmonary Arterial Hypertension Expense PAH Entity Tax Identification Number Entity Tax Identification Number Correction of Prior Period Immaterial Error: Error Correction [Text Block] Contingent consideration liability Contingent Consideration Liability Contingent Consideration Liability Balance, ending Balance, beginning Schedule of accrued expenses and other current liabilities. Schedule Of Accrued Expenses And Other Current Liabilities Table [Text Block] Schedule of Accrued Expenses and Other Current Liabilities Marketable Security, Unrealized Gain (Loss) Unrealized gain Marketable Securities, Unrealized Gain (Loss), Total Unrealized gain (loss) on marketable securities Unrealized gain (loss) on marketable securities Operating lease right-of-use assets Increase Decrease In Operating Lease Right Of Use Assets Increase Decrease In Operating Lease Right Of Use Assets Pre-Funded Warrant [Member] pre-funded Warrant [Member] Pre-Funded Warrant [Member] Schedule of Fair Value of Consideration Transferred [Table Text Block] Schedule of Fair Value of Consideration Transferred [Table Text Block] Schedule of fair value of consideration transferred Series of Individually Immaterial Asset Acquisitions [Member] Series of Individually Immaterial Asset Acquisitions Local Phone Number Local Phone Number Related Party Transaction [Domain] Debt Securities, Available-for-Sale, Unrealized Gain Marketable securities, Unrealized Gain Debt Securities, Realized Gain (Loss), Total Debt Securities, Realized Gain (Loss) Marketable securities, Unrealized Loss Marketable securities, Unrealized Gain Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Accounting Policies [Abstract] Amount of clinical trial supply Clinical Trial Supply Services Clinical Trial Supply Services Previously Reported Previously Reported [Member] Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Revenue from Contract with Customer, Excluding Assessed Tax, Total Revenue Fifth Restated Note Fifth Restated Note [Member] Fifth restated note. Numerator: Net Income (Loss) Attributable to Parent [Abstract] Class of Stock [Domain] Commercial Paper [Member] Commercial paper Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Number of shares available for grant Office Equipment Office Equipment [Member] Furniture and office equipment Schedule Of Stock By Class [Table] Stock, Class of Stock [Table] Entity Emerging Growth Company Entity Emerging Growth Company Indefinite-Lived Intangible Assets [Axis]